Shedir Pharma Group S.p.A. (BIT: SHE)

Shedir Pharma Group Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.71	1.23	15.77	19.07	16.43	6.1
Cash & Short-Term Investments	8.71	1.23	15.77	19.07	16.43	6.1
Cash Growth	-30.27%	-92.20%	-17.32%	16.06%	169.17%	106.85%
Accounts Receivable	9.5	13.66	13.41	10.31	9.92	11.35
Other Receivables	4.64	3.9	2.71	1.93	2.42	2.96
Receivables	14.14	17.56	16.12	12.24	12.35	14.31
Inventory	16.2	17.6	12.14	9.24	11.98	14.49
Prepaid Expenses	0.33	0.53	0.11	0.12	-	-
Other Current Assets	4	5	-	-	0	-0
Total Current Assets	43.39	41.92	44.13	40.66	40.76	34.9
Property, Plant & Equipment	6.96	7.84	5.05	5.88	5.98	6.64
Other Intangible Assets	5.08	5.54	6.5	4.93	5.08	5.33
Long-Term Deferred Tax Assets	0.07	0.05	0.04	0.13	0.1	0.04
Other Long-Term Assets	1.91	0.79	1.05	1.01	0.83	0.91
Total Assets	57.41	56.13	56.77	52.6	52.74	47.81
Accounts Payable	10.29	9.08	10.59	8.76	6.58	6.06
Accrued Expenses	0.99	0.66	1	1	1.02	2.38
Current Portion of Long-Term Debt	1.23	2.58	2.72	2.55	4.07	7.01
Current Portion of Leases	1.1	1.28	0.8	0.89	0.16	0.82
Current Income Taxes Payable	0.74	0.07	0.67	0.39	0.26	0.04
Other Current Liabilities	0.83	0.78	0.65	0.77	0.5	0.87
Total Current Liabilities	15.18	14.45	16.44	14.36	12.59	17.18
Long-Term Debt	1.53	2.16	4.02	5.45	7.94	2.07
Long-Term Leases	2.02	2.46	2.58	3.38	4.29	5.12
Long-Term Deferred Tax Liabilities	0.09	0.13	0.06	-	0	0
Other Long-Term Liabilities	0.87	0.83	0.79	1.18	1.08	0.75
Total Liabilities	19.69	20.03	23.88	24.36	25.91	25.12
Common Stock	1.93	1.93	1.93	1.93	1.93	1.93
Additional Paid-In Capital	8.58	8.58	8.58	8.58	8.58	8.58
Retained Earnings	2.12	6.27	6.49	4.28	4.07	2.84
Treasury Stock	-0.3	-0.3	-0.02	-	-	-
Comprehensive Income & Other	25.24	19.49	15.79	13.35	12.09	9.21
Total Common Equity	37.57	35.96	32.77	28.15	26.67	22.56
Minority Interest	0.14	0.14	0.12	0.1	0.17	0.14
Shareholders' Equity	37.72	36.1	32.89	28.24	26.84	22.69
Total Liabilities & Equity	57.41	56.13	56.77	52.6	52.74	47.81
Total Debt	5.88	8.49	10.12	12.27	16.46	15.02
Net Cash (Debt)	2.84	-7.26	5.64	6.8	-0.03	-8.92
Net Cash Growth	-12.63%	-	-17.04%	-	-	-
Net Cash Per Share	0.25	-0.64	0.49	0.60	-0.00	-
Filing Date Shares Outstanding	11.36	11.36	11.43	11.43	11.43	-
Total Common Shares Outstanding	11.36	11.36	11.43	11.43	11.43	-
Working Capital	28.21	27.47	27.69	26.3	28.17	17.72
Book Value Per Share	3.31	3.17	2.87	2.46	2.33	-
Tangible Book Value	32.5	30.43	26.27	23.22	21.59	17.23
Tangible Book Value Per Share	2.86	2.68	2.30	2.03	1.89	-
Land	0.99	0.99	0.99	0.99	0.99	0.99
Machinery	4.19	4.08	0.96	0.75	0.71	0.46
Construction In Progress	0.72	0.65	0.86	0.85	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.